Literature DB >> 7074554

Survival with malignant melanoma: a regression analysis of prognostic factors.

K T Drzewiecki, P K Andersen.   

Abstract

A Cox's regression model for survival data has been applied to investigate which of the many clinical and histopathologic parameters have a significant influence on the survival probability of the patients with primary malignant melanoma. The thicker the tumor and the deeper the invasion, the poorer the prognosis. Localization of the tumor on the mucous membranes, ulceration, and presence of epithelioid cells are all bad prognostic signs. The stronger the rim of inflammatory cell infiltrate, the better the prognosis for the patient. Females have better prognosis than males and prognosis aggravate with age. Using these parameters it is possible to make a prognosis forecast for the individual patient. Two patients, one with a favorable set of parameters and another with an unfavorable set, are described.

Entities:  

Mesh:

Year:  1982        PMID: 7074554     DOI: 10.1002/1097-0142(19820601)49:11<2414::aid-cncr2820491132>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  The significance of inflammation and regression in melanoma.

Authors:  M G Cook
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Adjusting and comparing survival curves by means of an additive risk model.

Authors:  P H Zahl; O O Aalen
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

3.  Confidence intervals for the cumulative incidence function via constrained NPMLE.

Authors:  Paul Blanche
Journal:  Lifetime Data Anal       Date:  2018-12-11       Impact factor: 1.588

4.  Diagnosis of malignant melanoma by general practitioners and hospital specialists.

Authors:  A M Jackson; D R Morgan; R Ellison
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

5.  Parametric modeling of localized melanoma prognosis and outcome.

Authors:  Shouluan Ding; Seng-Jaw Soong; Hui-Yi Lin; Renee Desmond; Charles M Balch
Journal:  J Biopharm Stat       Date:  2009-07       Impact factor: 1.051

6.  Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.

Authors:  E Ralfkiaer; K Hou-Jensen; K C Gatter; K T Drzewiecki; D Y Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  The extent of primary melanoma excision. A re-evaluation--how wide is wide?

Authors:  D R Aitken; K Clausen; J P Klein; A G James
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

8.  Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study.

Authors:  Marília B Espíndola; Oly C Corleta
Journal:  World J Surg Oncol       Date:  2008-06-20       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.